February 2023
166 articles-
Feb 28 · 11:29Biotechnology Daily
Could Pancreatic Cancer’s Reign as the Deadliest Common Cancer Soon Come to an End? – STRONG BUY
-
Feb 28 · 06:05Biotechnology Daily
J&J packs up HIV vaccine after failing phase 3 trial
-
Feb 28 · 06:04Biotechnology Daily
Bayer bolsters radiology division with Blackford AI acquisition
-
Feb 28 · 06:03Biotechnology Daily
SPAC to it: Alzheimer's-focused Aprinoia inks deal with Wilbur Ross' blank check company
-
Feb 28 · 06:02Biotechnology Daily
PsychoGenics on board for Iama's preclinical Dravet syndrome therapy study
-
Feb 28 · 06:01Bio Business News
Gilead fosters growth with plans for new research center in California hometown
-
Feb 28 · 06:00Bio Business News
PAVmed and its Lucid Diagnostics, Veris Health subsidiaries lay off 20% of staff
-
Feb 28 · 05:59Bio Business News
ReNeuron lays off 40% of staff after funding failure, buying time to execute exosome pivot
-
Feb 28 · 05:58Bio Business News
Mineralys polishes $100M IPO plans ahead of phase 3 in hypertension
-
Feb 27 · 01:45Biotechnology Daily
Irlab's shares plummet 60% after Ipsen-partnered Parkinson's drug flunks phase 2 trial
-
Feb 27 · 01:44Biotechnology Daily
Phase 2 attrition jumps amid widespread scale-back in overall clinical trial activity: study
-
Feb 27 · 01:43Biotechnology Daily
Will your smartphone be the next doctor's office?
-
Feb 27 · 01:41Biotechnology Daily
Akili lays off 30% of workforce, slims pipeline to bring prescription video games into 'mainstream medical care'
-
Feb 27 · 01:40Bio Business News
Playing catch-up to Big Pharma, Moderna posts come-from-behind RSV data
-
Feb 27 · 01:38Bio Business News
Horizon, on victory lap before Amgen buyout, racks up 2nd win in Sjögren's to claim unique double
-
Feb 27 · 01:37Bio Business News
With preclinical gene writing data on display, Tessera CEO's spirits not dampened by California's wild weather
-
Feb 27 · 01:35Bio Business News
Shockwave Medical's heart disease business gets a jolt with $100M Neovasc buy
-
Feb 23 · 22:58Biotechnology Daily
Caris teams up with ConcertAI on cancer trial data platforms
-
Feb 23 · 22:57Biotechnology Daily
First hiccup for Basilea's anti-infective strategy as biotech hands back antifungal 9 months after licensing it
-
Feb 23 · 22:57Biotechnology Daily
Abionyx hails success of bid to resurrect failed cholesterol drug—without dishing data to back up claims
-
Feb 23 · 22:56Biotechnology Daily
Many viruses, one sample: Sanger Institute launches project to sequence respiratory viruses, including co-infections
-
Feb 23 · 22:51Bio Business News
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market
-
Feb 23 · 22:49Bio Business News
Elicio uses struggling Angion as route to Nasdaq ahead of cancer vaccine's phase 2 move
-
Feb 23 · 22:48Bio Business News
TCR² removed 20% of staff over summer, paving way for latest layoffs